Sarda Proteins Closes Trading Window for Q2 2026 Results

Sarda Proteins Ltd has announced the closure of its trading window for dealing in the company's securities. This restriction will be in effect from Wednesday, July 1, 2026, until 48 hours after the declaration of the Unaudited Financial Results for the quarter ended June 30, 2026. The closure applies to designated persons, including directors, key managerial personnel, identified employees, and promoters, along with their immediate relatives, in compliance with SEBI's insider trading regulations. The date of the board meeting to approve these financial results will be communicated separately.